Oriheal Opthovet M Moxifloxacin 0.5% Ophthalmic Eye Drops for Dogs & Cats | Bacterial Conjunctivitis, Keratitis & Eye Infection | 5ml Veterinary Prescription

Prescription Required — For veterinary use only. Administer strictly under the supervision of a licensed veterinarian.

Oriheal Opthovet M Moxifloxacin Hydrochloride 0.5% Ophthalmic Eye Drops for Dogs & Cats (5ml)

Oriheal Opthovet M is a veterinary prescription ophthalmic solution containing Moxifloxacin Hydrochloride 0.5% (fourth-generation fluoroquinolone antibiotic), manufactured by Oriheal Lifesciences. Moxifloxacin is a broad-spectrum bactericidal fluoroquinolone with activity against gram-positive, gram-negative, and anaerobic bacteria — providing superior coverage compared to earlier-generation fluoroquinolones (ciprofloxacin, ofloxacin). Opthovet M is indicated for bacterial conjunctivitis, keratitis, blepharitis, and other bacterial ocular surface infections in dogs and cats.

Composition

• Moxifloxacin Hydrochloride — 0.5% w/v (fourth-generation fluoroquinolone antibiotic)
• Sterile isotonic ophthalmic vehicle base — q.s. to 5ml

Mechanism of Action

• Moxifloxacin inhibits two essential bacterial enzymes — DNA gyrase (topoisomerase II) and topoisomerase IV — simultaneously; this dual-target mechanism inhibits bacterial DNA replication, transcription, and repair, resulting in bactericidal activity
• Dual-target mechanism reduces the likelihood of resistance development compared to earlier fluoroquinolones that primarily target only one enzyme
• Broad-spectrum coverage: gram-positive organisms (Staphylococcus aureus, Streptococcus pneumoniae, coagulase-negative staphylococci), gram-negative organisms, and anaerobes — superior anaerobic coverage vs. ciprofloxacin and ofloxacin

Therapeutic Class

• Veterinary fourth-generation fluoroquinolone antibiotic ophthalmic prescription eye drops for dogs and cats — broad-spectrum bactericidal including anaerobes

Key Benefits

• Fourth-generation fluoroquinolone — broader spectrum than ciprofloxacin or ofloxacin; includes anaerobic and atypical bacterial coverage
• Dual-target mechanism (DNA gyrase + topoisomerase IV) — reduces resistance development risk
• Steroid-free antibiotic — suitable for use in bacterial infections with concurrent corneal ulceration (where corticosteroid-containing drops are contraindicated)
• 0.5% concentration — clinically effective for ocular surface bacterial infections

Indications

• Bacterial conjunctivitis in dogs and cats
• Bacterial keratitis and corneal surface infections
• Blepharitis — bacterial eyelid margin infections
• Broad-spectrum bacterial ocular surface infections including anaerobic involvement
• Post-surgical ocular antibiotic prophylaxis as directed by veterinarian

Directions for Use

• Instil 1–2 drops into the affected eye(s) as directed by a licensed veterinarian
• Frequency and duration determined by the prescribing veterinarian based on species, diagnosis, and clinical response
• Gently clean ocular discharge from around the eye before instillation if present
• Do not touch the dropper tip to the eye, eyelid, or any surface — replace cap immediately after use to maintain sterility

Safety Information

• Prescription medicine — for veterinary use only; administer under licensed veterinary supervision
• Steroid-free — suitable for bacterial eye infections with concurrent corneal ulceration
• Prolonged use may result in overgrowth of non-susceptible organisms or fungal superinfection — discontinue and seek veterinary advice if condition worsens or does not improve within expected timeframe
• Keep out of reach of children; store in a cool, dry place away from direct sunlight; discard after stated expiry